Yooma Wellness Inc. - MYO launches in Boots across the UK
RNS Number : 5463Y
Yooma Wellness Inc.
17 January 2022
 

17 January 2022

 

Yooma Wellness Inc.

('Yooma' or the 'Company' or the 'Group')

 

MYO Plant Nutrition launches in Boots across the UK

Products available in up to 838 stores across the UK

 

Yooma Wellness Inc. (CSE:YOOM; AQSE:YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, is pleased to announce that Boots, the UK's leading health and beauty retailer, will stock MYO Plant Nutrition ('MYO') products.

 

The listing includes MYO's Plant Proteins in 838 stores, branched-chain amino acids (BCAA) and essential amino acids (EAA) in up to 574 stores, and functional sprays in 522 stores.

 

Launching with Boots accelerates the momentum MYO has already seen in 2021, with products now available in Holland & Barrett, Selfridges, Lloyds Pharmacy and Amazon, amongst others.

 

MYO products are 100%-plant-based, use clean and innovative ingredients, and focus on the growing area of full-body plant-based wellness, which includes nutrition, the gut, brain, immunity and other key elements of wellness.  Furthermore, MYO holds a leading position with regards to sustainability by using recycled and recyclable outer packaging as well as biodegradable scoops and pouches.

 

James Lawson Baker, Founder of MYO Plant Nutrition, commented: "This is a major milestone for MYO and we are absolutely delighted to be partnering with Boots, the leading health and beauty retailer in the UK.  A listing of this size gives the brand enormous national exposure and deepens our footprint within mainstream UK retail.  The listing will support MYO in making plant-based active nutrition and wellness products mainstream and accessible.  The partnership is a testament to the high-quality product and brand offering that we have built over the past year.  We look forward to building our credibility amongst Boots' customers going forward."

 

Jordan Greenberg, CEO of Yooma, said: "MYO Plant Nutrition is an exceptional example of how Yooma's buy-and-build strategy creates shareholder value.  MYO continues to surpass expectations with its increased availability in UK's most reputable retailers and it has the honour of being known as one of the few brands to have passed the FSA's validation assessment."

 

Yooma acquired MYO in March 2021, due to the growing market demand for plant-based protein supplements, with a global market size estimated at US$4.3 billion in 2020, projected to grow at a CAGR of 7.2% during a forecast period 2021-2026.[1]

 

About MYO Plant Nutrition

MYO Plant Nutrition is a UK-based plant nutrition business with a mission to help people improve their full-body wellness. With a comprehensive product portfolio, MYO helps address the key areas of wellness including nutrition, performance, immunity, cognitive health and gut health.  MYO is one of the few brands whose CBD products have passed the UK Food Standard Agency's ("FSA") rigorous validation assessment and a number of products are included on the FSA's public list.  The brand is stocked in Boots, Holland & Barrett and Lloyds Pharmacy amongst others.  For further information visit www.myoplantnutrition.com.

 

About Yooma Wellness Inc.

Yooma's mission is to build a vertically-integrated global leader in the manufacturing, marketing, distribution, and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) ingredients.  The Company leverages strategically curated sales channels and ecommerce networks to deliver a diverse mix of wellness products through operating subsidiaries in the United States, United Kingdom, France and Japan.  Learn more at www.yooma.ca.

 

- Ends -

 

The directors of the company accept responsibility for the contents of this announcement.

 

For further information, please contact:

 

 

Yooma Wellness Inc.

Jordan Greenberg

 

 

Via Buchanan

 

 

MYO Plant Nutrition

James Lawson Baker

 

 

 

hq@myoplantnutrition.com

AQSE Corporate Adviser:

Peterhouse Capital Limited

Guy Miller / Mark Anwyl

 

 

Tel: +44 (0) 20 7469 0930

Tel: +44 (0) 7990 139 093

 

Media Enquiries

Buchanan

Henry Harrison-Topham / Jamie Hooper

Ariadna Peretz / George Beale

 

 

Tel: +44 (0) 20 7466 5000

yooma@buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXDZLFFLFLZBBF ]]>